|
Equity Method Investments (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | 3 Months Ended | 3 Months Ended | 3 Months Ended | 3 Months Ended | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nov. 28, 2013
|
Nov. 29, 2012
|
Aug. 29, 2013
|
Nov. 28, 2013
Primarily Inotera [Member]
|
Nov. 28, 2013
Inotera [Member]
|
Nov. 29, 2012
Inotera [Member]
|
Sep. 30, 2013
Inotera [Member]
|
Dec. 31, 2012
Inotera [Member]
|
Aug. 29, 2013
Inotera [Member]
|
Nov. 28, 2013
Inotera [Member]
Nanya [Member]
|
Nov. 28, 2013
Inotera [Member]
Inventories [Member]
|
Nov. 29, 2012
Inotera [Member]
Inventories [Member]
|
Nov. 28, 2013
Tera Probe [Member]
|
Nov. 29, 2012
Tera Probe [Member]
|
Aug. 29, 2013
Tera Probe [Member]
|
Aug. 29, 2013
Tera Probe [Member]
Elpida Company [Member]
|
Nov. 28, 2013
Other [Member]
|
Nov. 29, 2012
Other [Member]
|
Aug. 29, 2013
Other [Member]
|
Mar. 04, 2010
Other [Member]
Transform [Member]
|
Nov. 28, 2013
Other [Member]
Transform [Member]
|
Nov. 28, 2013
Other [Member]
Transform [Member]
Origin Energy Limited [Member]
|
Nov. 28, 2013
Other [Member]
Aptina [Member]
|
Mar. 01, 2012
Other [Member]
Aptina [Member]
|
Nov. 29, 2012
Nanya [Member]
|
|
| Schedule of Equity Method Investments [Line Items] | |||||||||||||||||||||||||
| Investment Balance | $ 490 | $ 396 | $ 437 | $ 344 | $ 42 | $ 40 | $ 11 | $ 12 | $ 0 | ||||||||||||||||
| Ownership Percentage (in hundredths) | 35.00% | 35.00% | 40.00% | 40.00% | 50.00% | 30.00% | |||||||||||||||||||
| Equity in net income (loss) of equity method investees, net of tax | 86 | (52) | 84 | (53) | 2 | 0 | 0 | 1 | |||||||||||||||||
| Maximum exposure to loss related to variable interest entities | 437 | ||||||||||||||||||||||||
| Percentage interest held by a third party (in hundredths) | 36.00% | 50.00% | |||||||||||||||||||||||
| Market value of equity interests | 1,470 | 36 | |||||||||||||||||||||||
| Amount in accumulated other comprehensive income (loss) for cumulative translation adjustments on its investment | 50 | 44 | |||||||||||||||||||||||
| Equity Method Investment, Summarized Financial Information [Abstract] | |||||||||||||||||||||||||
| Inotera current liabilities that exceed current assets | 766 | ||||||||||||||||||||||||
| Inotera net income (loss) | 333 | ||||||||||||||||||||||||
| Percentage of Inotera's wafer production previously obligated to purchase (in hundredths) | 50.00% | ||||||||||||||||||||||||
| Purchases of DRAM products from Inotera | 587 | 201 | |||||||||||||||||||||||
| Reduction in research and development costs under cost sharing arrangement | 15 | ||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||
| Ownership percentage after stock transactions during period (in hundredths) | 40.00% | 50.00% | |||||||||||||||||||||||
| Difference between cost of Tera Probe investment and underlying equity | $ 34 | ||||||||||||||||||||||||
| Weighted-average period for remaining basis difference amortization (in years) | 6 years | ||||||||||||||||||||||||